Correlation Between Keros Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Keros Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Keros Therapeutics and Aerovate Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Keros and Aerovate is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 1.53 times more return on investment than Aerovate Therapeutics. However, Keros Therapeutics is 1.53 times more volatile than Aerovate Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 1,137 in Keros Therapeutics on November 30, 2024 and sell it today you would lose (43.00) from holding Keros Therapeutics or give up 3.78% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Keros Therapeutics vs. Aerovate Therapeutics
Performance |
Timeline |
Keros Therapeutics |
Aerovate Therapeutics |
Keros Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Keros Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Keros Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Keros Therapeutics vs. Ideaya Biosciences | ||
Keros Therapeutics vs. AnaptysBio | ||
Keros Therapeutics vs. MeiraGTx Holdings PLC | ||
Keros Therapeutics vs. Janux Therapeutics |
Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |